Purpose & People

Pharmabiotic Research Institute (PRI) | EU Microbiome Regulatory Science Center

The Pharmabiotic Research Institute (PRI) is Europe’s first Microbiome Regulatory Science expertise center – our purpose is to support and foster the development of innovations emerging from microbiome science, by bridging stakeholders in industry, academia, and EU regulatory representatives.

Our mission is to educate and contribute to the conditions of success for future innovations emerging from microbiome science by supporting and communicating on regulatory science developments within and outside of our ecosystem.

Our ultimate objective: see these innovations achieve EU marketing authorization, for the ultimate benefit of citizens and patients.

To realize this vision, we apply a collaborative method called the ‘Share & Learn Approach’ – a pre-competitive process which combines microbiome expertise with strong regulatory science principles. These efforts are fundamental to identifying and confirming the specific requirements for the development of microbiome-based innovations.

Founded in 2010 by microbiologists from industry and academia, we operate as an independent, non-profit organization with a fully dedicated team of paid staff and a transparent governance structure.

PRI is now established as an Association Internationale Sans But Lucratif (AISBL) — an International Non-Profit Association under Belgian law. This legal framework reinforces our position at the heart of the European ecosystem and supports our role in engaging with national and European regulatory authorities.